AGER and arthritic joint disease: In both RAGE and WT animals, treatment with K/BxN serum induced highly active arthritis with no difference in disease severity (Figure 4, Supplement Figure S5), arguing against an impact of RAGE-signaling on the effector phase of joint inflammation, which is predominantly driven by innate immune cells.